Neoplasms, Lung: Clinical Trials

5 trials for Neoplasms, Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Active not recruiting 1, Recruiting 1
Phase 25Completed 3, Active not recruiting 1, Recruiting 1

Follow Neoplasms, Lung: new trials by email Literature Review of Neoplasms, Lung trials Research Report on Neoplasms, Lung

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
Risvutatug rezetecan, Ivonescimab - Neoplasms, Lung
Phase 1 / Phase 2RecruitingGlaxoSmithKline1842026-09-092026-09-23
Study of ESG401 in Adults With Solid Tumors
ESG401 - Neoplasms, Breast, Neoplasms, Lung
Phase 1 / Phase 2CompletedShanghai Escugen Biotechnology Co., Ltd1562021-09-142025-09-12
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2Active not recruitingNovartis Pharmaceuticals3442021-02-242026-10-19
The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine
cancer stem cell vaccine - Neoplasms, Lung
Phase 1 / Phase 2CompletedFuda Cancer Hospital, Guangzhou402014-03-012019-09-12
Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells
cancer stem cell vaccine - Neoplasms, Lung
Phase 1 / Phase 2CompletedFuda Cancer Hospital, Guangzhou402014-03-012015-06-03

Narrower conditions

Lung Neoplasms (5)  ·  Colorectal Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasm Metastasis (1)  ·  Ovarian Neoplasms (1)  ·  Stomach Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Lung Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Respiratory Tract Diseases (5)  ·  Respiratory Tract Neoplasms (5)  ·  Thoracic Neoplasms (5)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Rectal Diseases (2)  ·  Adnexal Diseases (1)

Interventions

JDQ443 (1)  ·  tislelizumab (1)

Sponsors

Fuda Cancer Hospital, Guangzhou (2)  ·  GlaxoSmithKline (1)  ·  Novartis Pharmaceuticals (1)  ·  Shanghai Escugen Biotechnology Co., Ltd (1)

Countries

China (4)  ·  Japan (2)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Fei Ma (1)

Results publications

PMID 22473314, PMID 36399068, PMID 39216478, PMID 40359710